Gilbert H. Tang

Dec 15, 2024 | mdpi.com | Gilbert H. Tang

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Ademayowa A. Ishola Ademayowa A. Ishola 1,*, James F. Whidborne James F. Whidborne 1 and Gilbert Tang Gilbert Tang 2 1Centre for Aeronautics, Cranfield University, Cranfield MK43 0AL, UK 2Centre for Robotics and Assembly, Cranfield University, Bedfordshire MK43 0AL, UK *Author to whom correspondence should be addressed.

Feb 5, 2024 | eurointervention.pcronline.com | Giuseppe Tarantini |Gilbert H. Tang |Luca Nai Fovino |Daniel Blackman

Introduction Transcatheter aortic valve implantation (TAVI) is an established therapy for elderly patients with severe symptomatic aortic valve stenosis (AS), irrespective of surgical risk123. The burden of coronary artery disease (CAD) is significant in patients with severe AS and may impact both the procedural risk as well as the post-procedural prognosis of the patient.